EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bringing Dermatology to the Frontline: Opportunities for DermTech in Primary Care Settings

Samruddhi Arkatkar, Riya Patel, Khwaja Hasan, Alisha Kashyap, Rashid Rashid

SKIN The Journal of Cutaneous Medicine · 14.07.2026 · 10 (4) · 3203-3210

DOI: 10.25251/fm649m35 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 14.07.2026. Verfasst von Samruddhi Arkatkar und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma accounts for a small fraction of skin cancer diagnoses in the United States yet is responsible for the most skin cancer-related mortality, highlighting the importance of early, accurate detection. Primary care physicians (PCPs) are first to evaluate suspicious pigmented lesions, but diagnostic accuracy is limited by time constraints, variable dermatologic training, and inconsistent access to dermoscopy, particularly in rural and underserved settings.

Objective

This narrative review examines the evidence supporting DermTech’s Pigmented Lesion Assay (PLA), a non-invasive adhesive patch that analyzes genomic markers associated with melanoma and evaluates its potential role in augmenting early skin cancer detection within primary care.

Findings

The PLA demonstrates high sensitivity, moderate specificity, and a negative predictive value exceeding 99%, enabling reliable exclusion of melanoma in clinically equivocal lesions. Clinical studies and registry data show that negative PLA results correlate with a very low likelihood of melanoma and reduced unnecessary biopsies and referrals. Integrating PLA into primary care may enhance triage accuracy, decrease specialty wait times, and expand access to molecular diagnostics in resource-limited settings. Challenges Implementation requires standardized training, workflow integration, and more consistent reimbursement. Additional validation in primary care populations is needed to assess real-world accuracy, cost-effectiveness, and patient outcomes. Inappropriate lesion selection may limit diagnostic yield.

Conclusion

DermTech’s PLA offers a promising adjunct to traditional lesion assessment in primary care by providing a painless, accessible method to rule out melanoma. With further research and implementation support, this technology may improve early detection, streamline referrals, and advance equitable skin cancer care.

Zitieren

APA

Arkatkar, S., Patel, R., Hasan, K., Kashyap, A., & Rashid, R. (2026). Bringing Dermatology to the Frontline: Opportunities for DermTech in Primary Care Settings. SKIN The Journal of Cutaneous Medicine, 10(4), 3203-3210. https://doi.org/10.25251/fm649m35

Vancouver

Arkatkar S, Patel R, Hasan K, Kashyap A, Rashid R. Bringing Dermatology to the Frontline: Opportunities for DermTech in Primary Care Settings. SKIN The Journal of Cutaneous Medicine. 2026;10(4):3203-3210. doi:10.25251/fm649m35

BibTeX
@article{Arkatkar2026,
  author = {Arkatkar, Samruddhi and Patel, Riya and Hasan, Khwaja and Kashyap, Alisha and Rashid, Rashid},
  title = {Bringing Dermatology to the Frontline: Opportunities for DermTech in Primary Care Settings},
  journal = {SKIN The Journal of Cutaneous Medicine},
  year = {2026},
  volume = {10},
  number = {4},
  pages = {3203--3210},
  doi = {10.25251/fm649m35}
}
Kostenlos starten →